4th edition – October 2012
 
 

Welcome to the fourth edition of the Coffee & Health quarterly news bulletin.

 
 
 
Join us on Twitter!

Coffee & Health is now on Twitter! Our Twitter name is @coffeeandhealth and you can follow us to view and share the latest research and news on coffee, caffeine and health. To follow us click here. We have also added new social features to the website, which can be found at the bottom of every page. These include options to share each page on Facebook, Twitter and Google Plus.

 
 
Topic updates

You may have spotted we’ve updated our Liver Function section and added new research to the materials. New research includes:

In 2011, a case-control study conducted in a Chinese population of hepatitis C chronic carriers found that moderate coffee consumption reduced the risk of hepatocellular carcinoma by almost half with a significant dose-response effect, reducing the risk for moderate coffee drinkers by 59%

A North American study to investigate the effects of dietary behaviour in non-alcoholic fatty liver disease patients, using four continuous cycles of the National Health and Nutrition Examination Surveys (NHANES 2001 -2008) found caffeine intake to be independently associated with a lower risk of non-alcoholic fatty liver disease NAFLD suggesting a potential protective effect

A French study developed to evaluate the impact of caffeine consumption on activity grade and fibrosis stage in patients with chronic hepatitis C found that caffeine consumption greater than 408 mg/day was associated with reduced histological activity in these patients

This is the first in a series of updates to the Coffee & Health website. For more information on the new research and to view the topic, click here.

 
 
ISIC sponsors workshop at World Congress on Prevention of Diabetes and its Complications

ISIC is sponsoring a workshop at the seventh World Congress on Prevention of Diabetes and its Complications, which is taking place in Madrid from 11 to 14 November.

Entitled ‘Good things in life: Can coffee help in diabetes prevention?’ the workshop will be chaired by P. Aschner, Colombia, and Siamak Bidel, Finland. The preliminary programme is as follows:

Nathan Matusheski, USA: Mechanistic theories on how coffee might act with regard to diabetes. Latest experiences from coffee intervention trials.

Matthias Schulze, Germany: Latest experiences from coffee intervention trials.

Pilar Riobó Serván, Spain: Significance of clinical parameters found so far regarding coffee and diabetes.

Edith Feskens, Netherlands: Coffee and reduced risk of type 2 diabetes – epidemiological evidence.

Session 1.1.2 takes place on 12 November, the second day of the congress, and will run from 11.30 to 13.00. For further information on the conference please visit the website here.

 
 
Highlights from the ESC Congress 2012

On 25 August, more than 28,000 cardiologists from around the world descended upon Munich for the 2012 European Society of Cardiology (ESC) Congress. Over the five day conference, delegates had the opportunity to learn about the latest research affecting their practice.

This year saw the announcement of six new ESC guidelines – including an updated guideline on cardiovascular disease prevention. This guideline was presented by Professor Joep Perk from Sweden, who highlighted that 50% of the reductions in cardiovascular mortality are due to reduction in risk factors and 40% due to improved treatments. The new guideline has put forward important emphasis and recommendations on improvement in risk factors.

Recent evidence suggests that moderate coffee drinking does not increase the risk of cardiovascular disease. Research also suggests that, in both men and women, drinking coffee in moderation may reduce their risk of stroke, but no firm conclusion has yet been drawn.

For more information on the new guideline and to view a webcast of the session, click here.

To view the cardiovascular health topic on the Coffee & Health website, click here.

 
 
New research studies published

Have you caught up recently with the latest research on Coffee & Health? We regularly publish abstracts of new research papers in the research centre so make sure you visit us on a frequent basis or subscribe to the RSS feed. Recent studies published include:

Total antioxidant capacity is important in the prevention of myocardial infarction
S Rautiainen et al, 2012. Total Antioxidant Capacity from Diet and Risk of Myocardial Infarction: A Prospective Cohort of Women, The American Journal of Medicine, Volume 125.

The data found that dietary total antioxidant capacity, based on fruits, vegetables, coffee, and whole grains, is of importance in the prevention of myocardial infarction. For more information, click here.

Coffee could help protect against bowel cancer
R Sinha et al, 2012. Caffeinated and decaffeinated coffee and tea intakes and risk of colorectal cancer in a large prospective study. American Journal of Clinical Nutrition, Volume 96; 374-381.

In this large US cohort, coffee was inversely associated with colon cancer, particularly proximal tumors. Additional investigations of coffee intake and its components in the prevention of colorectal cancer by subsites are warranted. For more information, click here.

No significant association between coffee consumption and the risk of gastric and/or pancreatic cancers
S Bidel et al, 2012. Coffee consumption and risk of gastric and pancreatic cancer: a prospective cohort study, International Journal of Cancer, published online ahead of print.

The study, designed to evaluate the relationship between coffee consumption and risk of gastric and pancreatic cancer among Finns, whose coffee consumption is the highest in the world, did not find a significant association. For more information, click here.
 
 
Fact or Fiction? Drinking coffee helps improve sports performance

FACT: The effects of coffee consumption on sports performance are linked to the caffeine in coffee, rather than to coffee itself.

The European Food Safety Authority (EFSA) recently stated that a cause and effect relationship has been established for caffeine intake and increased endurance performance, endurance capacity, and a reduction in perceived exertion. Caffeine is effective at doses of 3-4mg/kg. Caffeine may moderate central fatigue and influence ratings of perceived exertion, pain and levels of vigour, all of which are likely to lead to improvements in performance.

To download our Fact or Fiction leaflet, which is a quick-reference guide to help health care professionals respond to some of the most frequently asked questions about coffee and health, click here.

To view our vodcast on coffee and sports performance, click here.

To view the sports performance topic on the Coffee & Health website, click here.
 
 
 

If you have not already signed up to receive the newsletter by email, to stay up-to-date with all the latest news on coffee and health, click here.

 

 
 

This email was sent to [email address suppressed]. If you are no longer interested you can unsubscribe instantly.